Evoke Pharma Inc (EVOK)
0.4788
-0.07
(-12.79%)
USD |
NASDAQ |
Apr 18, 16:00
0.5037
+0.02
(+5.20%)
After-Hours: 20:00
Evoke Pharma Cash from Operations (TTM): -4.985M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.985M |
September 30, 2023 | -6.385M |
June 30, 2023 | -6.444M |
March 31, 2023 | -6.612M |
December 31, 2022 | -6.596M |
September 30, 2022 | -6.087M |
June 30, 2022 | -10.88M |
March 31, 2022 | -11.01M |
December 31, 2021 | -12.35M |
September 30, 2021 | -12.07M |
June 30, 2021 | -7.986M |
March 31, 2021 | -8.031M |
December 31, 2020 | -6.63M |
September 30, 2020 | -6.066M |
June 30, 2020 | -5.315M |
March 31, 2020 | -5.387M |
December 31, 2019 | -5.762M |
September 30, 2019 | -5.863M |
June 30, 2019 | -5.954M |
March 31, 2019 | -6.088M |
December 31, 2018 | -6.979M |
September 30, 2018 | -8.463M |
June 30, 2018 | -9.514M |
Date | Value |
---|---|
March 31, 2018 | -9.848M |
December 31, 2017 | -8.717M |
September 30, 2017 | -7.353M |
June 30, 2017 | -7.571M |
March 31, 2017 | -7.704M |
December 31, 2016 | -8.708M |
September 30, 2016 | -9.791M |
June 30, 2016 | -9.877M |
March 31, 2016 | -10.19M |
December 31, 2015 | -10.50M |
September 30, 2015 | -10.56M |
June 30, 2015 | -11.97M |
March 31, 2015 | -12.50M |
December 31, 2014 | -11.50M |
September 30, 2014 | -10.87M |
June 30, 2014 | -7.232M |
March 31, 2014 | -4.594M |
December 31, 2013 | -3.040M |
September 30, 2013 | -1.804M |
June 30, 2013 | -1.831M |
March 31, 2013 | -1.749M |
December 31, 2012 | -1.750M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-12.35M
Minimum
Dec 2021
-4.985M
Maximum
Dec 2023
-7.390M
Average
-6.444M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
Eton Pharmaceuticals Inc | 6.815M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |